Dudka, Wioleta
Hoser, Grazyna
Mondal, Shamba S.
Turos-Korgul, Laura
Swatler, Julian
Kusio-Kobialka, Monika
Wołczyk, Magdalena
Klejman, Agata
Brewinska-Olchowik, Marta
Kominek, Agata
Wiech, Milena
Machnicki, Marcin M.
Seferynska, Ilona
Stoklosa, Tomasz
Piwocka, Katarzyna
Article History
Received: 24 July 2022
Accepted: 7 November 2022
First Online: 2 December 2022
Declarations
:
: All in vivo experiments on mice (immunodeficient NOD.Cg-PrkdcscidIl2rgtm1WjL/SzJ mice), were performed in accordance with the Poland’s National Ethics Committee for Animal Experimentation and the Animal Protection Act in Poland (Directive 2010/63/EU). All protocols and experiments were carried out in relevant guidelines and regulations, and were approved by the Second Local Ethics Committee (Permission No. WAW/51/2016).Patients’ material was obtained from the Institute of Hematology and Blood Transfusion in Warsaw, Poland, following informed written consent, in accordance with the Declaration of Helsinki and the guidelines for good clinical practice. All protocols were approved by the local Ethical Committee (Ethical and Bioethical Committee UKSW, Approval No. KEiB-19/2017, Approval No.WAW2/059/2019 and WAW2/51/2016).All used methods are reported in accordance with the ARRIVE guidelines.
: Not applicable.
: The authors declare no competing financial interests.